SAN DIEGO Dec 2 (Reuters) - Novo Nordisk in 2020 launched pivotal trials of its GLP-1 drug semaglutide in Alzheimer's patients based on studies ​in humans, animals and real-world findings, a top company executive said on Tuesday, acknowledging ‌criticism that Novo's studies had design flaws. Although the trials failed to show statistically significant slowing of cognitive decline in patients given the drug,‌ "we still think it was the right decision.

Washington, D.C., the capital of the US, is wealthy ever, culture, and notorious milestones. This casting a ballot article features six of the top priority attractions in Washington, D.C., each offe

The ruling rejected Safdi’s claim that his admissions during Shin Bet (Israel Security Agency) and Israel Police questioning had been extracted through improper pressure. The Nazareth District Court convicted Tahrir Safdi, a resident of Mas’ada in the Golan Heights, of espionage for Iran after finding that, over several years, he passed sensitive information on IDF activity in the North, including tank movements and missile impact locations, through a Syria-based contact he suspected was linked